12 January 2021 A Phase II Trial of Everolimus in Patients with Advanced Pancreatic Neuroendocrine Carcinoma Refractory or Intolerant to Platinum-Containing Chemotherapy (NECTOR Trial). View PDF
Recent News UKINETS Spring Newsletter available now Launching the new NET App, developed by UKINETS and NCUK Cancer registry data on NETs Please take part in our Survey of Dietetic Practice in Neuroendocrine Tumours across the UK & Ireland BNMS Virtual Spring Meeting 2021
Sign up for our newsletterSign-up for our email newsletter. Simply give us your email address in the box below to sign-up.Email
